Answers are grounded in this paper and cite their sources.
In Brief Endotoxin from Gram-negative bacteria is a microbial cell wall agent that is present in all environments, and an important exposure route is by inhalation. Deposition of endotoxin or the chemically pure substance lipopolysaccharide in the airways causes a neutrophil-dominated inflammation with the liberation of inflammatory cytokines, which act both locally and systemically. Clinical entities are cough, airway irritation, and decreased pulmonary function. At high exposure levels, toxic pneumonitis (fever, influenza-like symptoms) may develop. Several epidemiologic studies suggest that exposure to endotoxin-containing dusts in childhood and also as adults decreases the risk for atopic sensitization, eczema, and possibly allergic asthma. Some studies suggest a lower risk for lung cancer. Although the relation to these effects is suggestive, it is not possible to conclude that endotoxin is the causative agent. From a clinician's point of view, it is important to realize that acute symptoms of airways inflammation and toxic pneumonitis may be related to endotoxin and other microbial cell wall agents. For the proper care of patients there is also a need to distinguish between asthma caused by nonspecific inflammation and by a reaction to an allergen in the airways. This review describes the presence of bacterial endotoxin in the environment, delineates the cellular reactions after inhalation, and the clinical diseases related to exposure. Endotoxin causes an increased risk for inflammation in the airways. Some data suggest a reduced risk for atopic sensitization and lung cancer.
No takes yet. Share an insight, caveat, or question.
Ragnar Rylander (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: